Skip to content

FDA Approves Eli Lilly's GLP-1 Pill

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

schedule 18:56 visibility 40 views
FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.

Related Articles

Read More

How the Amazon Echo learned to talk — and listen
Health

How the Amazon Echo learned to talk — and listen

Jeff Bezos badly wanted a voice computer. He had been saying so publicly since the very early days of Amazon, telling anyone who would listen about why voice might make it easier and more natural to interact with technology. (And to buy stuff from...

The Verge